JP2011517689A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517689A5
JP2011517689A5 JP2011504377A JP2011504377A JP2011517689A5 JP 2011517689 A5 JP2011517689 A5 JP 2011517689A5 JP 2011504377 A JP2011504377 A JP 2011504377A JP 2011504377 A JP2011504377 A JP 2011504377A JP 2011517689 A5 JP2011517689 A5 JP 2011517689A5
Authority
JP
Japan
Prior art keywords
quinolin
yloxy
phenyl
fluoro
dimethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011504377A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011517689A (ja
JP5746015B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/002798 external-priority patent/WO2009127417A1/en
Publication of JP2011517689A publication Critical patent/JP2011517689A/ja
Publication of JP2011517689A5 publication Critical patent/JP2011517689A5/ja
Application granted granted Critical
Publication of JP5746015B2 publication Critical patent/JP5746015B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011504377A 2008-04-16 2009-04-16 Axlキナーゼ阻害剤としてのキノリン誘導体 Active JP5746015B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4539808P 2008-04-16 2008-04-16
US61/045,398 2008-04-16
PCT/EP2009/002798 WO2009127417A1 (en) 2008-04-16 2009-04-16 Quinoline derivatives as axl kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2011517689A JP2011517689A (ja) 2011-06-16
JP2011517689A5 true JP2011517689A5 (https=) 2012-05-31
JP5746015B2 JP5746015B2 (ja) 2015-07-08

Family

ID=40999731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011504377A Active JP5746015B2 (ja) 2008-04-16 2009-04-16 Axlキナーゼ阻害剤としてのキノリン誘導体

Country Status (12)

Country Link
US (1) US9206130B2 (https=)
EP (1) EP2262772B8 (https=)
JP (1) JP5746015B2 (https=)
KR (1) KR101325237B1 (https=)
CN (1) CN102131783A (https=)
AU (1) AU2009237938A1 (https=)
CA (1) CA2718538A1 (https=)
ES (1) ES2391373T3 (https=)
IL (1) IL208103A (https=)
MX (1) MX2010011224A (https=)
RU (1) RU2010146474A (https=)
WO (1) WO2009127417A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311809A1 (en) * 2009-10-16 2011-04-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Quinolinyloxyphenylsulfonamides
EP2423208A1 (en) 2010-08-28 2012-02-29 Lead Discovery Center GmbH Pharmaceutically active compounds as Axl inhibitors
ITRM20100537A1 (it) 2010-10-12 2012-04-12 Consiglio Nazionale Ricerche Aptamero inibitore del recettore tirosina chinasi axl per uso in terapia
EP2780338B1 (en) * 2011-11-14 2016-11-09 Ignyta, Inc. Uracil derivatives as axl and c-met kinase inhibitors
RS55728B1 (sr) 2012-01-31 2017-07-31 Daiichi Sankyo Co Ltd Derivat piridona
CA2879542A1 (en) 2012-07-25 2014-01-30 Salk Institute For Biological Studies Regulating the interaction between tam ligands and lipid membranes with exposed phosphatidylserine
TWI649308B (zh) 2013-07-24 2019-02-01 小野藥品工業股份有限公司 喹啉衍生物
JP6527513B2 (ja) 2013-11-20 2019-06-05 シグナルケム・ライフサイエンシーズ・コーポレイションSignalchem Lifesciences Corporation Tamファミリーキナーゼ阻害剤としてのキナゾリン誘導体
CA2922542A1 (en) 2013-11-22 2015-05-28 University Of Kentucky Research Foundation Arylquinoline and analog compounds and use thereof to treat cancer
JP6496731B2 (ja) 2013-11-27 2019-04-03 シグナルケム・ライフサイエンシーズ・コーポレイションSignalchem Lifesciences Corporation Tamファミリーキナーゼ阻害剤としてのアミノピリジン誘導体
TWI690525B (zh) 2014-07-07 2020-04-11 日商第一三共股份有限公司 具有四氫吡喃基甲基之吡啶酮衍生物及其用途
WO2016104617A1 (ja) * 2014-12-25 2016-06-30 小野薬品工業株式会社 キノリン誘導体
US9840503B2 (en) 2015-05-11 2017-12-12 Incyte Corporation Heterocyclic compounds and uses thereof
WO2017027717A1 (en) 2015-08-12 2017-02-16 Incyte Corporation Bicyclic fused pyrimidine compounds as tam inhibitors
US10053465B2 (en) 2015-08-26 2018-08-21 Incyte Corporation Pyrrolopyrimidine derivatives as TAM inhibitors
WO2017146236A1 (ja) 2016-02-26 2017-08-31 小野薬品工業株式会社 Axl阻害剤と免疫チェックポイント阻害剤とを組み合わせて投与することを特徴とする癌治療のための医薬
MD3436461T2 (ro) 2016-03-28 2024-05-31 Incyte Corp Compuși pirolotriazină ca inhibitori TAM
CN108250200A (zh) * 2016-12-28 2018-07-06 中国科学院上海药物研究所 一种具有Axl抑制活性的化合物及其制备和应用
EP3575293B1 (en) 2017-01-26 2021-03-10 ONO Pharmaceutical Co., Ltd. Ethanesulfonate salt of n-{5-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-pyridinyl}-2,5-dioxo-1-phenyl-1,2,5,6,7,8-hexahydro-3-quinolinecarboxamide
JP7156287B2 (ja) 2017-08-23 2022-10-19 小野薬品工業株式会社 Axl阻害剤を有効成分として含むがん治療剤
MX2020002183A (es) * 2017-08-31 2020-10-05 Abbvie Inc Inhibidores de la ectonucleótido pirofosfatasa-fosfodiesterasa 1 (enpp-1) y usos de los mismos.
SI3687996T1 (sl) 2017-09-27 2022-04-29 Incyte Corporation Soli pirolotriazinskih derivatov, ki so uporabne kot zaviralci TAM
EP3695839A4 (en) 2017-10-13 2021-07-14 ONO Pharmaceutical Co., Ltd. THERAPEUTIC AGENT WITH AXL INHIBITOR AS AN ACTIVE INGREDIENT FOR SOLID TUMORS
MD3813800T2 (ro) 2018-06-29 2025-10-31 Incyte Corp Formulări de inhibitor al AXL/MER
US20220143049A1 (en) 2019-03-21 2022-05-12 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
EP4054579A1 (en) 2019-11-08 2022-09-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
EP4114401A1 (en) 2020-03-06 2023-01-11 Incyte Corporation Combination therapy comprising axl/mer and pd-1/pd-l1 inhibitors
JP2023525757A (ja) * 2020-05-08 2023-06-19 ジョージアミューン・インコーポレイテッド Akt3モジュレーター
JP2022104746A (ja) * 2020-12-29 2022-07-11 国立研究開発法人国立がん研究センター 抗がん剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9510757D0 (en) * 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
IL144461A0 (en) 1999-01-22 2002-05-23 Kirin Brewery Quinoline and quinazoline derivatives and pharmaceutical compositions containing them
US7041691B1 (en) * 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
AU2003280599A1 (en) * 2002-10-29 2004-05-25 Kirin Beer Kabushiki Kaisha QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
PT2213661E (pt) * 2003-09-26 2011-12-15 Exelixis Inc Moduladores de c-met e métodos de uso
GB0509227D0 (en) * 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Intracellular enzyme inhibitors
CA2619037A1 (en) * 2005-08-22 2007-03-01 Boehringer Ingelheim International Gmbh Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
JP2009539878A (ja) * 2006-06-08 2009-11-19 アレイ バイオファーマ、インコーポレイテッド キノリン化合物および使用方法
WO2008076415A1 (en) 2006-12-14 2008-06-26 Exelixis, Inc. Methods of using mek inhibitors

Similar Documents

Publication Publication Date Title
JP2011517689A5 (https=)
RU2010146474A (ru) Производные хинолина в качестве ингибиторов axl киназ
JP2013525293A5 (https=)
JP4731114B2 (ja) 置換スルホンアミド化合物、cns障害、肥満およびii型糖尿病の処置のための医薬としてのそれらの使用方法
RU2394021C2 (ru) Новое производное антраниловой кислоты или его соль
AU2017253937B2 (en) Compounds and compositions for treating conditions associated with NLRP activity
US20220227732A1 (en) Pyridine carboxamide compounds for inhibiting nav1.8
JP2005526056A (ja) フタルイミドカルボン酸誘導体
RU2576036C2 (ru) Модуляторы активности нес1 и способы для них
ES2297382T3 (es) Derivados de sulfonamida como moduladores de ppar.
RU2563639C2 (ru) Замещенные соединения амида
CA3025887C (en) Sulfonamide compound or salt thereof
RU2008116581A (ru) Сульфонамидные производные, как активаторы гликокиназы, применимые для лечения диабета типа 2
WO2008048991A2 (en) Organic compounds
CA2757761A1 (en) Sulfamoyl benzoic acid derivatives as trpm8 antagonists
AU2007282465C1 (en) Sulfonamide compound or salt thereof
US20070276011A1 (en) Plasminogen Activator Inhibitor-1 Inhibitor
JP2008545686A5 (https=)
RU2007100229A (ru) Производные сульфонамида
RU2460723C2 (ru) Производные 4-(1-аминоэтил)циклогексиламина
RU2006116421A (ru) Анилиды салициловой кислоты
RU2013120137A (ru) Производные тетрагидрохинолина в качестве активаторов амрк
CA2628875A1 (en) Diaryl ureas for treating diabetic neuropathy
RU2017115036A (ru) Производные бензилгидроксида, их получение и их терапевтическое применение
MXPA06006211A (en) Biaryl sulfonamides as mmp inhibitors